Therefore, the present study aims to investigate the ability of CD134+ and PD-1+CD4+ T-cells of human SLE patients to produce effector cytokines IFN-γ, IL-21 and IL-22 ex vivo. The gene discussed is TNFRSF4; the disease is systemic lupus erythematosus.